Search

Your search keyword '"Utili, Riccardo"' showing total 854 results
Start Over Author "Utili, Riccardo"
854 results on '"Utili, Riccardo"'

4. Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

Author

Durante-Mangoni, Emanuele, Signoriello, Giuseppe, Andini, Roberto, Mattei, Annunziata, De Cristoforo, Maria, Murino, Patrizia, Bassetti, Matteo, Malacarne, Paolo, Petrosillo, Nicola, Galdieri, Nicola, Mocavero, Paola, Corcione, Antonio, Viscoli, Claudio, Zarrilli, Raffaele, Gallo, Ciro, and Utili, Riccardo

Published
2013
Full Text
View/download PDF

12. Emergence of Coagulase-Negative Staphylococci as a Cause of Native Valve Endocarditis

Author

Chu, Vivian H., Woods, Christopher W., Miro, Jose M., Hoen, Bruno, Cabell, Christopher H., Pappas, Paul. A., Federspiel, Jerome, Athan, Eugene, Stryjewski, Martin E., Nacinovich, Francisco, Marco, Francesc, Levine, Donald P., Elliott, Tom S., Fortes, Claudio Q., Tornos, Pilar, Gordon, David L., Utili, Riccardo, Delahaye, Francois, Corey, Ralph, and Fowler,, Vance G.

Published
2008
Full Text
View/download PDF

15. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial

Author

Utili, Riccardo, Sagnelli, E., Giusti, G., Ruggiero, G., Piccinino, F., Galanti, B., Adinolfi, L. E., Aprea, L., Cesaro, G., Digilio, L., Felaco, F. M., Filippini, P., Gaeta, G. B., Marrone, A., Nardiello, S., Pasquale, G., Pizzella, T., Russo, M., Santarpia, L., Sardaro, C., D’Amora, T., De Bac, C., editor, Taliani, G., editor, and Gerlich, W. H., editor

Published
1992
Full Text
View/download PDF

23. Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure

Author

Kiefer, Todd, Park, Lawrence, Tribouilloy, Christophe, Cortes, Claudia, Casillo, Roberta, Chu, Vivian, Delahaye, Francois, Durante-Mangoni, Emanuele, Edathodu, Jameela, Falces, Carlos, Logar, Mateja, Miró, José M., Naber, Christophe, Tripodi, Marie Françoise, Murdoch, David R., Moreillon, Philippe, Utili, Riccardo, and Wang, Andrew

Published
2011
Full Text
View/download PDF

25. Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis–Prospective Cohort Study

Author

Murdoch, David R., Corey, Ralph G., Hoen, Bruno, Miró, José M., Fowler, Vance G., Jr, Bayer, Arnold S., Karchmer, Adolf W., Olaison, Lars, Pappas, Paul A., Moreillon, Philippe, Chambers, Stephen T., Chu, Vivian H., Falcó, Vicenç, Holland, David J., Jones, Philip, Klein, John L., Raymond, Nigel J., Read, Kerry M., Tripodi, Marie Francoise, Utili, Riccardo, Wang, Andrew, Woods, Christopher W., and Cabell, Christopher H.

Published
2009
Full Text
View/download PDF

26. Current Features of Infective Endocarditis in Elderly Patients: Results of the International Collaboration on Endocarditis Prospective Cohort Study

Author

Durante-Mangoni, Emanuele, Bradley, Suzanne, Selton-Suty, Christine, Tripodi, Marie-Françoise, Barsic, Bruno, Bouza, Emilio, Cabell, Christopher H., de Oliveira Ramos, Auristela Isabel, Fowler, Vance, Jr, Hoen, Bruno, Koneçny, Pam, Moreno, Asuncion, Murdoch, David, Pappas, Paul, Sexton, Daniel J., Spelman, Denis, Tattevin, Pierre, Miró, José M., van der Meer, Jan T. M., and Utili, Riccardo

Published
2008

27. Candida infective endocarditis: report of 15 cases from a prospective multicenter study

Author

Falcone, Marco, Barzaghi, Nicoletta, Carosi, Giampiero, Grossi, Paolo, Minoli, Lorenzo, Ravasio, Veronica, Rizzi, Marco, Suter, Fredy, Utili, Riccardo, Viscoli, Claudio, and Venditti, Mario

Subjects
Endocarditis -- Distribution, Endocarditis -- Causes of, Endocarditis -- Patient outcomes, Endocarditis -- Research, Candidiasis -- Distribution, Candidiasis -- Patient outcomes, Candidiasis -- Demographic aspects, Candidiasis -- Research, Company distribution practices
Published
2009

32. Unusual Cases of Infective Endocarditis

Author

Caruso, Aurelio, Iarussi, Diana, Dialetto, Giovanni, Covino, Franco, Crispo, Claudio, Coppolino, Pasquale, Tripodi, Maria Francoise, and Utili, Riccardo

Published
2002

33. Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C

Author

DURANTE MANGONI, Emanuele, Parrella, Antonio, Vitrone, Martina, Rago, Anna, Pafundi, Pia Clara, NIGRO, Gerardo, UTILI, Riccardo, Russo, Vincenzo, DURANTE MANGONI, Emanuele, Parrella, Antonio, Vitrone, Martina, Rago, Anna, Pafundi, Pia Clara, Nigro, Gerardo, Utili, Riccardo, and Russo, Vincenzo

Subjects
direct antiviral agent, electrocardiography, hepatitis C, arrhythmia, sofosbuvir
Abstract

Recently, several cases of symptomatic, sometimes fatal bradycardia during the first days of direct-acting antiviral (DAA) (eg, sofosbuvir [SOF]) administration have been reported. We analyzed in detail electrocardiographic (ECG) changes during SOF- or non-SOF-based chronic hepatitis C (CHC) treatment, specifically focusing on bradyarrhythmias. All 39 consecutive patients treated at our center with any interferon-free regimen between June and December 2015 were included in this study (26 SOF-based therapy vs 13 no-SOF interferon-free regimens). ECG tracings were obtained from all patients the first day of treatment and after 7, 14, and 28 days. ECG parameters (P-wave, QRS, QT interval, JT interval, T(apex) -T(end) interval duration) were compared between the 2 groups at baseline and at the 3 different time points during antiviral therapy. There were no cases of symptomatic bradycardia/syncope. In the SOF group, QTc duration rose after 1 week (from 424.3 to 431.2 milliseconds; P = .013) and returned to baseline during therapy. QT dispersion dropped since week 1 (from 85.6 to 67.2 milliseconds) and remained significantly reduced until the end of the observation period (72.9 msec) (P = .003). JT dispersion reduced up to week 2 (P = .010) and returned to baseline at week 4; in the no-SOF group, QRS dispersion transiently reduced (from 41 to 34.5 milliseconds, day 7). No other significant changes were observed in the remaining parameters. In CHC patients treated with SOF and other DAAs, ECG parameter changes were mild and/or transient and did not translate into clinically significant electrophysiological effects in the absence of amiodarone coadministration. Recently, several cases of symptomatic, sometimes fatal bradycardia during the first days of direct-acting antiviral (DAA) (eg, sofosbuvir [SOF]) administration have been reported. We analyzed in detail electrocardiographic (ECG) changes during SOF- or non-SOF-based chronic hepatitis C (CHC) treatment, specifically focusing on bradyarrhythmias. All 39 consecutive patients treated at our center with any interferon-free regimen between June and December 2015 were included in this study (26 SOF-based therapy vs 13 no-SOF interferon-free regimens). ECG tracings were obtained from all patients the first day of treatment and after 7, 14, and 28 days. ECG parameters (P-wave, QRS, QT interval, JT interval, T-apex-T-end interval duration) were compared between the 2 groups at baseline and at the 3 different time points during antiviral therapy. There were no cases of symptomatic bradycardia/syncope. In the SOF group, QTc duration rose after 1 week (from 424.3 to 431.2 milliseconds; P = .013) and returned to baseline during therapy. QT dispersion dropped since week 1 (from 85.6 to 67.2 milliseconds) and remained significantly reduced until the end of the observation period (72.9 msec) (P = .003). JT dispersion reduced up to week 2 (P = .010) and returned to baseline at week 4; in the no-SOF group, QRS dispersion transiently reduced (from 41 to 34.5 milliseconds, day 7). No other significant changes were observed in the remaining parameters. In CHC patients treated with SOF and other DAAs, ECG parameter changes were mild and/or transient and did not translate into clinically significant electrophysiological effects in the absence of amiodarone coadministration.

Published
2017

37. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial

Author

Utili, Riccardo, primary, Sagnelli, E., additional, Giusti, G., additional, Ruggiero, G., additional, Piccinino, F., additional, Galanti, B., additional, Adinolfi, L. E., additional, Aprea, L., additional, Cesaro, G., additional, Digilio, L., additional, Felaco, F. M., additional, Filippini, P., additional, Gaeta, G. B., additional, Marrone, A., additional, Nardiello, S., additional, Pasquale, G., additional, Pizzella, T., additional, Russo, M., additional, Santarpia, L., additional, Sardaro, C., additional, and D’Amora, T., additional

Published
1992
Full Text
View/download PDF

45. Primary sclerosing cholangitis in patient with celiac disease complicated by cholecystic empyema and acute pancreatitis

Author

Piccolboni P, Ragone E, Inzirillo A, UTILI, Riccardo, Piccolboni, P, Ragone, E, Inzirillo, A, and Utili, Riccardo

Subjects
Cholangiopancreatography, Endoscopic Retrograde, Male, Cholagogues and Choleretics, Biopsy, Cholangitis, Sclerosing, Ursodeoxycholic Acid, Middle Aged, Esophageal and Gastric Varices, Clinical Practice, Celiac Disease, Jaundice, Obstructive, Sphincterotomy, Endoscopic, Treatment Outcome, Pancreatitis, Acute Disease, Cholecystitis, Humans, Cholecystectomy, Gastrointestinal Hemorrhage, Ligation, Follow-Up Studies
Abstract

The association of celiac disease and sclerosing cholangitis is a well known, although unusual, pathologic feature of autoimmunity.A 64 year old patient presenting with sub-acute cholangitis and pancreatitis, treated with cholecystectomy and endoscopic sphincterotomy. The post-operative course, complicated by cholestatic jaundice, and subsequent clinical complications are described, showing how the diagnosis of sclerosing cholangitis was outlined after the Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and confirmed by liver biopsy. Long term treatment with Ursodeoxycholic acid has gradually normalized bilirubin values, while cholestasis enzymes are gradually decreasing. After 18 months bleeding from oesophageal varices ensued, which was controlled through endoscopic ligation.The diagnosis of primary sclerosing cholangitis should be taken into account when cholangitis is associated with other immunity derangements and segmentary dilatations of the intra-hepatic bile ducts, but no dilatation of the main bile duct is noticed at imaging or endoscopy. Recovery of hepatic function should be always attempted before bringing the patient to surgery, in order to avoid postoperative hepatic decompensation.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results